Intra-Cellular Therapies (ITCI) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/10/20
Intra-Cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/10/20
Intra-Cellular Therapies to Host Second Quarter 2020 Financial Results Conference Call and WebcastGlobeNewsWire • 08/04/20
Intra-Cellular Therapies Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Heart FailureGlobeNewsWire • 06/29/20
How Intra-Cellular Therapies (ITCI) Stock Stands Out in a Strong IndustryZacks Investment Research • 06/11/20
Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/07/20
Intra-Cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/07/20
Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 04/16/20
RBC Has 5 Biotech Stocks Rated Outperform With Up to 100% Upside Potential24/7 Wall Street • 04/14/20
Stocks To Watch: Intra-Cellular Therapies Sees Relative Strength Rating Rise To 93Investors Business Daily • 04/07/20
Intra-Cellular Therapies Initiates Promotional Activities for CAPLYTA™ (lumateperone) for the Treatment of Schizophrenia in AdultsGlobeNewsWire • 04/02/20
Intra-Cellular Therapies (ITCI): Strong Industry, Solid Earnings Estimate RevisionsZacks Investment Research • 03/27/20
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with SchizophreniaGlobeNewsWire • 03/23/20
Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/02/20
Why Intra-Cellular Therapies (ITCI) Might Surprise This Earnings SeasonZacks Investment Research • 02/25/20
Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 02/21/20
Pivotal Study of CAPLYTA™ (lumateperone) for the Treatment of Schizophrenia in Adults Published in JAMA PsychiatryGlobeNewsWire • 02/20/20
Implied Volatility Surging for Intra-Cellular (ITCI) Stock OptionsZacks Investment Research • 01/21/20